-2022

Paiania, 28 March 2023 – Lavipharm S.A., according to the provisions of article 19 of the European Regulation No 596/2014 and the Regulation of the Athens Exchange, announces the appointment of Mr. Evangelos Paterakis as Chief Accountant replacing Mr. Panagiotis Pavlou, who is retiring.   ###...

Peania, 15 March 2023 - Lavipharm S.A. announces the key financial figures for 2022 and business developments in its activity: Lavipharm Flash Note FY2022 ...

Peania, 6 March 2023 - Lavipharm S.A, pursuant to articles 4.1.2 & 4.1.3.15.1 of the Athens Stock Exchange Rulebook, announces the Financial Calendar of 2023, as follows : FINANCIAL CALENDAR 2023...